Funding for this research was provided by:
Konsul TH C Bergh Foundation, Sweden
Accepted: 8 January 2021
First Online: 9 February 2021
Compliance with Ethical Standards
: T. Gülen has received lecture fees from Thermo Fisher. C. Akin has received consultancy fees from Blueprint Medicines and Novartis and has a patent for LAD2 cells.
: This article does not contain any studies with human or animal subjects performed by any of the authors.